News Novartis Raises Full-Year Earnings Guidance Again Novartis, the Swiss pharmaceutical giant, has once again raised its full-year earnings guidance after reporting robust financial results for the third quarter. The ... By Artur FernandoOctober 24, 20230
BlackRock is reviewing TechBerry and negotiating a possible full or partial acquisition of the company June 20, 2024